The neurofibromatosis 2 (NF2) tumor suppressor protein, merlin, functions as a negative growth regulator; however, the molecular mechanisms that underlie merlin regulation remain elusive. Recent studies have implicated merlin phosphorylation in regulating merlin subcellular localization and growth suppression. P21-activated kinase (PAK), a downstream target of Rac1/Cdc42, directly phosphorylates merlin at Serine 518. In this report, we show that PAK2 directly phosphorylates wild-type merlin, whereas merlin truncation mutants with impaired GST-aminoterminal domain (N-term or NTD)/GST-carboxy-terminal domain (C-term or CTD) intramolecular association exhibit impaired S518 phosphorylation. We directly demonstrate that PAK2 phosphorylation impairs merlin N-term/C-term binding in vitro and in vivo. Lastly, we show that PAK2 phosphorylation impairs the ability of merlin to bind to two interacting proteins, CD44 and hepatocyte growth factor-regulated tyrosine kinase substrate (HRS), both critical for merlin growth suppression. These observations suggest that merlin S518 phosphorylation directly modulates merlin intramolecular and intermolecular associations important for the ability of merlin to function as a tumor suppressor.
Introduction
The neurofibromatosis 2 (NF2) tumor suppressor gene encodes an intracellular membrane-associated protein, called merlin or schwannomin, which belongs to the band 4.1 family of cytoskeleton-associated proteins that link cell surface glycoproteins to the actin cytoskeleton (Tsukita et al., 1994) . Merlin is a 595 amino-acid protein composed of three predicted structural domains (Rouleau et al., 1993; Trofatter et al., 1993) . The aminoterminal domain (NTD) (FERM domain), spanning residues 1-302, contains the highly conserved sequences found in other ERM proteins important for interactions with cell surface glycoproteins, including CD44 and intercellular adhesion molecules (Chishti et al., 1998; Hamada et al., 2000) . The central domain (residues 303-478) contains a predicted a-helix region, which is also present in ERM proteins. The carboxyl-terminal domain (CTD) of merlin (residues 479-595) is unique and lacks the conventional actin-binding motif found in ERM proteins. In contrast, merlin directly binds actin using residues in the GST-N-terminal domain (N-term) of the protein as well as indirectly through its association with bII-spectrin or fodrin (Scoles et al., 1998) .
Merlin growth suppression is dependent on the ability of merlin to form a productive N-term/GST-N-terminal domain (C-term) association (Sherman et al., 1997; Gutmann et al., 1999a) . In this regard, merlin exists in 'open' (inactive form) and 'closed' (active growth suppressive form) conformations that are regulated by an intramolecular association between the N-and Ctermini of the protein (Gutmann et al., , 1999a Gonzalez-Agosti et al., 1999; Meng et al., 2000) . Merlin isoform I containing exon 17 (amino-acid residues LTLQSAKSRVAFFEEL) can form an N-term/C-term intramolecular complex ('closed' conformation) . In contrast, the alternatively spliced merlin isoform II, containing exon 16 (amino-acid residues PQAQGRR-PICI) and lacking exon 17 sequences as a result of a premature termination codon, only weakly forms an intramolecular complex, and exists in an 'open' conformation that cannot function as a negative growth regulator (Sherman et al., 1997) . Similarly, merlin molecules with mutations in the N-or C-term as well as some NF2 patient missense mutations in the N-or Cterm exhibit an 'open' conformation and do not suppress cell growth . In addition, merlin intramolecular folding has been shown to modulate binding to HRS, a merlin binding protein necessary for merlin growth suppression (Sun et al., 2002) . In this regard, merlin cannot inhibit mouse embryonic fibroblast growth in the absence of HRS expression, suggesting that merlin growth suppression requires HRS.
In addition to binding to HRS, merlin associates with the CD44 cell surface glycoprotein, schwannomininteracting protein-1 (SCHIP1), bII-spectrin or fodrin, and other ERM proteins (Sainio et al., 1997; Scoles et al., 1998; Goutebroze et al., 2000; Meng et al., 2000; Morrison et al, 2001) . The importance of the interaction with CD44 is underscored by the observation that interference with merlin binding to CD44 impairs merlin growth suppression in RT4 rat schwannoma cells (Morrison et al., 2001) . In addition, CD44 preferentially associates with hypophosphorylated merlin, and relatively little phosphorylated merlin binds CD44. The relationship between merlin binding to the other interacting proteins and growth suppression has not been elucidated.
Merlin subcellular localization and growth suppression have recently been shown to be modulated by merlin phosphorylation (Kissil et al., 2002) . Studies from a number of groups have shown that merlin is directly phosphorylated on Serine 518 (Ser518) by members of the P21-activated kinase (PAK) family of kinases, including PAK1 and PAK2 (Shaw et al., 2001; Kissil et al., 2002; Xiao et al., 2002) . Using an antibody directed against merlin phosphorylated on Ser518, Kissil et al. (2002) demonstrated that phosphorylated merlin is mislocalized to the cytoplasm, and is not expressed at the cell membrane. In addition, we have recently shown that a merlin mutant that mimics Ser518 phosphorylation (S518D) cannot suppress cell growth or motility in RT4 rat schwannoma cells, and results in dramatic changes in cell morphology and actin cytoskeleton organization (Surace et al., 2004) . In the present report, we directly examine the impact of Ser518 phosphorylation on merlin intramolecular and intermolecular associations, and demonstrate that merlin Ser518 phosphorylation modulates N-term/C-term merlin interactions as well as binding to two merlin-interacting proteins, CD44 and HRS, which are critical for merlin growth suppression.
Results

PAK2 differentially phosphorylates merlin isoforms and merlin mutants
Previous studies have shown that PAK2 can directly phosphorylate merlin on Ser518 (Shaw et al., 2001; Kissil et al., 2002; Xiao et al., 2002) . Using the phosphoSer518 HM-2175 antibody (Kissil et al., 2002) , we sought to determine whether both isoforms of merlin could be phosphorylated by activated PAK2, since only merlin isoform I forms a productive N-term/C-term intramolecular association and functions as a negative growth regulator. Both merlin I and II isoforms contain exons 1-15, which includes Ser518. To determine whether merlin II can also act as a substrate for PAK2, we assayed its phosphorylation on Ser518 using the HM-2175 phospho-Ser518 specific antibody (Kissil et al., 2002) in the presence or absence of an activated PAK2 molecule. PAK is activated by binding of monomeric (p21) G-proteins such as Cdc42 and Rac, and subsequent autophosphorylation at a threonine residue in the activation loop. PAK-T402E mimics activated full-length PAK (Lim et al., 1996; Bagrodia and Cerione, 1999) . Previous studies have shown that the PAK2 T402E mutant is an active kinase, and results in merlin S518 phosphorylation and relocalization (Kissil et al., 2002; Xiao et al., 2002) .
Compared to the Ser518 phosphorylation observed with the functionally active merlin isoform I, no phosphorylation was observed with the functionally inactive merlin isoform II. As a negative control, no phosphorylation was seen with a merlin mutant in which Ser518 was replaced with a nonphosphorylatable alanine residue (S518A). Interestingly, no Ser518 phosphorylation was observed with merlin containing the NF2 patient L64P missense mutation (Figure 1a , left top or empty vector and several merlin constructs, including merlin isoform I, isoform II, a patient-derived mutant L64P, and a nonphosphorylatable S518 A mutant. After harvesting cells, Western blotting was performed using the HM-2175-Ser518-phospho-specific antibody to evaluate the phosphorylation status at Ser518 of the different merlin molecules (top panels). Expression levels of PAK2 and merlin were verified using specific antibodies (middle and bottom panels). Only merlin isoform I exhibited PAK2-mediated phosphorylation at Ser518. No S518 phosphorylation was observed in the control group where no PAK2 was present (left panels). (b) Several merlin truncation mutants previously analysed for their ability to form an intramolecular association were transfected into HEK293 cells. Cells were harvested and Western blotting using the Ser518 phospho-specific antibody was performed (top panel). All mutants, except the ahelical domain internal truncation mutant (D340-452) showed reduced S518 phosphorylation. Merlin expression levels were determined using a nonphospho merlin antibody (bottom panel). Ability of these truncation mutants to bind to polymerized microtubules and suppress cell growth is shown Phosphorylation mediates merlin protein associations R Rong et al panel). The expression levels of Myc-PAK2 and merlin were verified using specific antibodies ( Figure 1a , left middle and bottom panels). No S518 phosphorylation was observed in the control group without PAK2 ( Figure 1a , right panels). Collectively, these results raise the intriguing possibility that Ser518 phosphorylation requires that merlin be capable of forming a productive N-term/C-term intramolecular association.
PAK2 differentially phosphorylates merlin mutants with impaired N-term/C-term binding
To explore the possibility that the differences in merlin Ser518 phosphorylation reflected impaired merlin intramolecular complex formation, we next examined a series of merlin truncation mutants previously analysed for their ability to form an N-term/C-term association (Gutmann et al., 1999a) . All of these mutants except the a-helical domain internal truncation mutant (D340-452; data not shown) have impaired N-term/C-term binding, as reflected by their ability to bind polymerized microtubules . In addition, merlin D340-452 suppressed cell growth similar to wildtype merlin in rat schwannoma cells (data not shown).
We found that all of these mutants, except D340-452, exhibited reduced Ser518 phosphorylation in the presence of activated PAK2. The expression of the transfected merlin constructs was determined by Western blot using a nonphospho-merlin antibody (sc331), and was used to calculate the relative percent of Ser518 merlin phosphorylation (Figure 1b, lower panel) . No Ser518 phosphorylation was observed in any transfected proteins in the absence of PAK2 (data not shown). Collectively, these data support the notion that merlin molecules with impaired N-term/C-term binding have altered Ser518 phosphorylation.
PAK2 phosphorylation of merlin directly impairs N-term/ C-term interaction
Previous studies have suggested that a carboxyl-terminal domain (CTD) merlin fragment containing a mutation that mimics Ser518 phosphorylation (S518D) exhibited reduced binding to an NTD merlin fragment (Shaw et al., 2001) . To determine whether Ser518 phosphorylation directly impairs merlin intramolecular domain association, we examined this interaction in vitro and in vivo. First, we performed an in vitro binding assay employing purified GST-merlin-NTD (amino acid residues 1-332). The purified recombinant protein was incubated with lysates from HEK293 cells, which were cotransfected with constitutively active Myc-PAK2 and HA-merlin-CTD-I (amino acid residues 342-595) or HA-merlin CTD-II (amino acid residues 342-590).
In these in vitro binding experiments, S518 phosphorylation substantially abrogated the binding of merlin CTD-I to the GST-merlin-NTD ( To further assess whether Ser518 phosphorylation abolishes the interaction between the N-and C-termini of merlin in vivo, we next performed GST pull-down assays by cotransfecting HEK293 cells with HA-merlin-NTD and mammalian GST-merlin-CTD-I or -CTD-II constructs in the presence or absence of activated Myc-PAK2 in vivo. Merlin-CTD was collected on glutathione beads, and the proteins analysed by Western blot. Consistent with in vitro binding assay, these in vivo GSTinteraction experiments demonstrated that Ser518 phosphorylation abolished binding by merlin-CTD-I to its N-terminus. As before, the weak association between merlin-CTD-II and its N-terminus was not affected by PAK2 phosphorylation (Figure 2b, bottom panel) . Expression of the transfected constructs was verified by Western blot (Figure 2b , top, second and third panels), and merlin phosphorylation on S518 was demonstrated using the HM-2175 antibody (Figure 2b , fourth panel). As a negative control, GST alone does not bind to HA-merlin-NTD.
Merlin phosphorylation has been postulated to inactivate merlin and result in an 'open' conformation (Morrison et al., 2001; Lallemand et al., 2003) . Our data support this hypothesis by directly demonstrating that Ser518 phosphorylation abolishes the association between N-and C-termini of merlin. The ability of PAK to regulate merlin intramolecular association is similar to that reported for the modulation of ERM protein folding by phosphorylation (Matsui et al., 1998) .
PAK2 phosphorylation modulates binding of merlin to CD44, fodrin and HRS
Previous studies by Morrison et al. (2001) demonstrated that merlin associates with the transmembrane hyaluronic acid receptor CD44 when merlin is in a hypophosphorylated state under conditions of high cell density and growth arrest. In contrast, phosphorylated merlin does not bind CD44 efficiently. To determine whether merlin phosphorylation at Ser518 affects the association of merlin with its interacting proteins, we analysed the ability of merlin to bind directly to GST fusion proteins containing CD44, bII-spectrin (fodrin), SCHIP1, HRS and ezrin. In these experiments, we purified the various GST-recombinant proteins, and incubated them with lysates from HEK293 cells transfected with merlin isoform I in the presence or absence of activated PAK2. Bound proteins were then analysed with antimerlin antibodies (sc331). PAK2-mediated merlin phosphorylation significantly decreased merlin binding to CD44 and HRS, but had minimal effects on ezrin and SCHIP1 binding. In contrast, PAK2-mediated merlin phosphorylation significantly increased the binding of merlin isoform I to fodrin (Figure 3a , left and right panels). The expression of each of the purified GSTrecombinant proteins was verified (Figure 3b ). Our findings are consistent with previous data demonstrating that fodrin binding to the C-terminus of merlin is masked in native protein, such that the coexpression of the N-terminus of merlin decreases the interaction of its C-terminus with fodrin (Neill and Crompton, 2001 ). In addition, recent experiments have shown that merlin containing a mutation that mimics Ser518 phosphorylation (S518D) results in dramatic alterations in actin cytoskeleton organization and cell morphology (Surace et al., 2004) . In this regard, merlin folding has been shown to influence its membrane localization and actin cytoskeleton association (Brault et al., 2001) . Collectively, our results with fodrin binding raise the possibility that merlin phosphorylation regulates its subcellular localization and results in the acquisition of new biological properties that relate to increased binding to actin cytoskeleton-associated proteins (e.g. fodrin).
The 'hyperphosphorylated' merlin mutant, S518D, exhibits reduced binding to merlin binding partners, CD44 and HRS To provide additional support for the effect of merlin S518 on merlin binding to CD44 and HRS, we performed in vitro and in vivo binding assays using two merlin S518 phosphorylation-mimicking mutants. S518A mimics merlin hypophosphorylation, while S518D mimics merlin hypophosphorylation. Previous studies using RT4 rat schwannoma cell lines inducibly expressing these mutants demonstrated that S518A functioned like wild-type merlin with regard to growth and motility inhibition, while S518D was functionally inactive in these assays (Surace et al., 2004) . We observed a reproducible decrease in HRS binding in the S518D merlin mutant compared to the S518A mutant using in vitro GST affinity binding (Figure 4a) . By scanning densitometry, this reduction ranges between 50 and 75% (n ¼ 3 separate experiments). In vivo interaction experiments demonstrated a similar effect on CD44 cytoplasmic tail binding, with the S518D mutant exhibiting a twofold reduction in CD44 binding (n ¼ 3 separate experiments; Figure 4b ). Collectively, these experiments provide direct evidence for impaired binding between merlin and its two functionally important binding partners, and correlate well with the PAK2 phosphorylation results shown in Figure 3a .
Discussion
Over the past several years, a number of laboratories have shown that merlin is phosphorylated on Ser518, suggesting that phosphorylation might represent one mechanism for regulating merlin function. Previous studies in our laboratory have demonstrated that a Figure 2 PAK2 phosphorylation of merlin directly impairs Nterm/C-term interaction. (a) HEK293 cells were cotransfected with either constitutively active Myc-PAK2 or empty vector and HAmerlin CI (residues 342-595) or HA-merlin CII (residues 342-590). Cells were harvested and lysates incubated with GST-merlin N-term (residues 1-332). Merlin CI binding to the N-term is abrogated by PAK2-mediated phosphorylation at Ser518 (bottom panel, lanes 1 and 3). Merlin CII weak binding to N-term is not affected by phosphorylation (bottom panel, lanes 2 and 4). Myc-PAK2 and merlin expression levels were assessed using specific antibodies (top panels). Phosphorylation status at Ser518 was verified by the HM-2175-Ser518-phospho-specific antibody. (b) HEK293 cells were transfected with HA-merlin-NTD, mammalian GST-merlin CI or CII and Myc-PAK2. Cell lysates were incubated with glutathione beads to collect GST-merlin-CTD. Western blot using an anti-HA antibody confirmed that PAK2-mediated phosphorylation abrogated N-term/CI-term binding (bottom panel, lanes 1 and 3). Merlin CII binding was not affected by phosphorylation (bottom panel, lanes 2 and 4). Expression levels of Myc-PAK2 and merlin were confirmed using specific antibodies. Phosphorylation status at Ser518 was verified by the HM-2175-Ser518-phospho-specific antibody Phosphorylation mediates merlin protein associations R Rong et al Ser518 hyperphosphorylation-mimicking mutant is unable to suppress rat schwannoma cell growth or inhibit cell motility (Surace et al., 2004) . In addition, merlin phosphorylation has also been implicated in modulating merlin interactions with its associated binding partners. To provide direct evidence for PAK-mediated merlin phosphorylation regulation of merlin protein interactions, we determined the consequence of merlin Ser518 phosphorylation on merlin intermolecular and intramolecular associations. In this report, we demonstrate that Ser518 phosphorylation results in impaired merlin Nterm/C-term folding as well as altered interactions with critical merlin-associated proteins. Recently, Alfthan et al. (2004) demonstrated that protein kinase-A (PKA) induces merlin phosphorylation on both N-and C-terminal residues in vitro and in vivo Like PAK, PKA can phosphorylate merlin at Ser518, but unlike PAK, also results in merlin phosphorylation on Ser66 in the N-terminal domain. In their study, they show that merlin can be phosphorylated by PKA in cells, in which PAK activity was suppressed, indicating that these two kinases likely function independently. Using a GST-merlin-CTD fusion protein, which was treated with or without purified PKA, they show that the N-terminus of ezrin (amino-acid residues 1-309) strongly binds to a PKA-phosphorylated, but not untreated, merlin CTD. In contrast, we show that PAK2-induced S518 phosphorylation has a minimal effect on the interaction between full-length merlin and full-length ezrin. In our experiments, we employed a purified GST-full-length ezrin fusion protein, and cell lysates from HEK293 cells cotransfected with full-length merlin and PAK2 (Figure 3a) . These results are similar to those previously observed in our laboratory, in which both S518A and phosphomimic (S518D) mutants bind to full-length ezrin with similar affinity in vitro (Surace et al., 2004) . The apparent discrepancy in the merlinezrin interaction data might result from the use of different forms of the ezrin and merlin molecules as well as the different kinases utilized in the binding assays. In this regard, it has been well established that the Nterminus of ezrin can exert a regulatory influence over its C-terminus either in cis or trans (Gary and Bretscher, 1995; Martin et al., 1995) . Further studies comparing the effects of PKA phosphorylation on merlin function and protein associations will be required to define the potential differences between PKA-and PAK-mediated merlin phosphorylation.
The dramatic effects of PAK2-mediated merlin phosphorylation on merlin binding to CD44 and HRS is exciting in light of prior studies demonstrating that CD44 and HRS binding to merlin is critical for NF2 Figure 3 PAK2 phosphorylation modulates binding of merlin to its interacting proteins. (a) HEK293 cells were cotransfected with Myc-PAK2 or empty vector and merlin isoform I and incubated with the different GST fusion proteins. Bound proteins were then analysed by Western blot using an anti-merlin antibody (sc331) (top panels). PAK2-mediated phosphorylation decreased merlin binding to CD44 and HRS, but had minimal effects on binding to SCHIP1 and ezrin. Merlin binding to fodrin was significantly increased by PAK2-induced phosphorylation. Expression level of PAK2 was verified using an anti-myc antibody (bottom panel). (b) GST fusion proteins of different known merlin interactors (CD44, fodrin, SCHIP1, HRS and ezrin) were prepared as described in the Experimental procedures section. Fusion proteins were collected on glutathione beads, washed and resuspended in TEN buffer. A measure of 20 ml of each slurry was resolved by PAGE. Gels were Coomassie stained to confirm protein production Figure 4 The 'hyperphosphorylated' merlin mutant, S518D, exhibits reduced binding to merlin binding partners, CD44 and HRS. (a) Binding of S518D and S518A merlin to HRS was assessed using GST fusion protein affinity chromatography in vitro as described in the Experimental procedures section. Bound and total proteins are shown for each interaction. Scanning densitometry revealed a 75% reduction in binding of the S518D merlin to HRS compared to S518A merlin. (b) RT4 cells were cotransfected with His-CD44 cytoplasmic tail and S518A or S518D merlin. Cells were lysed and incubated with Ni-NTA agarose. Bound and total proteins were analysed by Western blot using anti-merlin antibodies. Scanning densitometry showed a twofold reduction in S518D/CD44 binding compared to S518A
Phosphorylation mediates merlin protein associations R Rong et al growth suppression. In these reports, expression of a CD44 cytoplasmic tail decoy reversed merlin growth suppression in RT4 rat schwannoma cells (Morrison et al., 2001) , suggesting that the interaction between merlin and endogenous CD44 is essential for transducing the high-density growth arrest signal propagated by merlin. Similarly, merlin growth suppression required the expression of HRS to suppress cell growth in fibroblasts (Sun et al., 2002) , supporting the notion that merlin growth regulation operates at least in part through HRS. The results described herein implicate merlin phosphorylation in the regulation of these two important merlin protein interactions. Coupled with our previous report using Ser518 phosphomutants, in which merlin containing the S518A, but not S518D, mutation was able to function as a negative growth regulator, we propose a model in which cells maintained at low cell density under conditions permissive for cell growth induce PAK activity to result in merlin Ser518 phosphorylation. Phosphorylated merlin is then rendered inactive, and can no longer bind efficiently to its two interacting proteins, CD44 and HRS. In contrast, under growth arrest conditions (high cell density), PAK is not activated and merlin remains hypophosphorylated, where it can associate with both CD44 and HRS to propagate a growth arrest signal.
In addition, the observation that merlin Ser518 phosphorylation by PAK modulates merlin binding to fodrin, an actin cytoskeleton-associated protein, raises the attractive possibility that merlin phosphorylation results in loss of merlin growth suppression by converting 'active' merlin to an ERM protein. We have previously found that, while the S518D hyperphosphorylation-mimicking mutant is defective as a negative growth regulator, it can induce dramatic changes in the actin cytoskeleton and the extension of long processes (Surace et al., 2004) , similar to that observed with ezrin (Martin et al., 1995 (Martin et al., , 1997 Bonilha et al., 1999) . In this respect, ezrin overexpression has no effect on rat schwannoma cell growth (CA Haipek and DH Gutmann, unpublished observations). Based on these findings, we hypothesize that the phosphorylation of merlin on Ser518 results in an unfolded merlin protein, which now can function as an ERM molecule and impact on actin cytoskeleton-associated processes. Further work will be necessary to define the relationship between merlin phosphorylation and the acquisition of ERM functional properties.
The recent studies by Kissil and co-workers have shown that merlin can also function to inhibit PAK activity (Kissil et al., 2003; Hirokawa et al., 2004) , suggesting an intimate relationship between merlin and PAK, in which PAK can inhibit merlin function and merlin can, in turn, suppress PAK activity. This reciprocal regulation suggests that merlin growth suppression is a tightly regulated process, and that the target of merlin inhibition might also be involved in regulating merlin function. In addition, the finding that both PKA and PAK can result in merlin phosphorylation suggests that multiple pathways might converge to impact on merlin growth regulation. Further work will be required to define this intriguing and complex modulation of merlin protein associations, intramolecular folding and growth suppression by protein phosphorylation events.
Materials and methods
Plasmids and reagents
The GST-tagged merlin isoform I, NTD or N-term fragment (amino-acid residues 1-332) and CTD or C-term fragment (amino-acid residues 340-595) cloned into the pGEX bacterial expression vector were kindly provided by Dr Vijaya Ramesh (Harvard Medical School). Merlin missense and truncation mutants were generated as described previously Gutmann et al., 1999a Gutmann et al., , 2001 . GST fusion proteins for SCHIP1, HRS, fodrin and CD44 were generated as reported previously (Gutmann et al., 1999b , while the GST-full-length ezrin was a generous gift from Dr Heinz Furthmayr (Stanford University). Full-length human merlin containing a serine to alanine (S518A) or serine to aspartic acid (S518D) mutation was generated as reported previously (Surace et al., 2004) . Mouse monoclonal anti-HA-HRP, antiMyc-HRP and anti-GST antibodies were from Sigma. Rabbit polyclonal anti-NF2 antibody (sc331) was from Santa Cruz Biotechnology. The HM-2175 anti-phospho-S518 merlin antibody was a gift from Drs Tyler Jacks and Joseph Kissil (MIT; Kissil et al., 2002) . Glutathione-Sepharose 4B was supplied by Pharmacia Biosciences. All the chemicals were purchased from Sigma.
Cell culture
The rat RT4-D6-P2T schwannoma cells stably transfected with merlin isoform I containing the L64P mutation (http:// neuro-trials1.mgh.harvard.edu/nf2/) and wild-type merlin isoform I (5 4 , 6 7 two clones; gifts from Dr Peter Herrlich, Karlsruhe, Germany) were maintained in DMEM, supplemented with 10% fetal bovine serum, 2 mg/ml glutamine, 100 U penicillin-streptomycin, 500 mg/ml G-418 at 371C with 5% CO 2 atmosphere in a humidified incubator. The induction was triggered by 1 mg/ml doxycycline for 24 h incubation (Morrison et al., 2001) .
PAK phosphorylation and in vitro binding assays
GST-merlin-NTD (amino-acid residues 1-332) fusion protein was prepared according to the manufacturer's recommendations (Pharmacia Biotech) and coupled to glutathioneSepharose beads. At 24 h after transfection with HA-tagged merlin-CTD-I or merlin-CTD-II constructs alone, or cotransfection with 5 mg of Myc-PAK2, HEK293 cells were washed once in ice-cold phosphate-buffered saline (PBS) and lysed in 500 ml lysis buffer A (50 mM Tris, pH 7.4, 40 mM NaCl, 1 mM EDTA, 0.5% Triton X-100, 1.5 mM Na 3 VO 4 , 50 mM NaF, 10 mM sodium pyrophosphate, 10 mM sodium b-glycerophosphate, 1 mM phenylmethylsulfonyl flouride (PMSF), 5 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mg/ml pepstatin A), and centrifuged for 10 min at 14 000 g at 41C. 500 mg of cell lysate were added to 50 ml GST-merlin-NTD-conjugated agarose, and incubated with slow rotation at 41C for 3 h, and washed three times with 500 ml lysis buffer. The bound proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), followed by immunoblotting with anti-HA-HRP antibody at a 1 : 2000 dilution. The expression level of transfected constructs and S518 phosphor-ylation was confirmed with immunoblotting with anti-HA-HRP and anti-phospho-S518 (HM2175) antibodies.
GST-pull down for merlin of C-and N-terminal domain interactions
The HEK293 cells were cotransfected with 5 mg each of HAtagged merlin-NTD (amino-acid residues 1-332), mammalian GST-tagged merlin-CTD-I (amino-acid residues 342-595) or merlin CTD-II (amino-acid residues 342-590), and Myc-PAK2 or empty vector. The supernatant was prepared as above. After the protein concentrations were normalized, 40 ml 50% slurry glutathione beads were added to the supernatant and incubated with rotation at 41C for 3 h. The pellet was washed three times with 500 ml lysis buffer each time, and the associated proteins were resolved by SDS-PAGE followed by immunoblotting using anti-HA antibody at a 1 : 2000 dilution. The protein expression levels were confirmed by immunoblotting analysis with anti-HA, Myc and GST antibodies.
The HEK293 cells were cotransfected with Myc-PAK2 or empty vector and HA-merlin CTD-I or HA-merlin CTD-II. Cells were harvested and lysates incubated with glutathioneagarose beads-immobilized GST-merlin-NTD (amino-acid residues 1-332) at 41C for 3 h. Pellets were processed as described above.
S518 phosphomerlin mutant binding experiments
For the in vitro binding experiments, GST fusion protein (GST) or GST fusion protein containing full-length HRS (HRS) were immobilized on glutathione and incubated with [ 35 S]methionine merlin containing either the S518A or S518D mutation using protocols operational in our laboratory (Sherman et al., 1997; Robb et al., 2003) . Aliquots of the total radiolabeled protein and total eluted proteins were separated by SDS-PAGE and analysed by autoradiography. For the in vivo binding experiments, His-tagged CD44 cytoplasmic tail and merlin mutants were cotransfected into RT4 rat schwannoma cells using Lipofectamine and harvested 48 h later as previously reported by our laboratory (Gutmann et al., 1999b; Robb et al., 2003) . Proteins bound to His-CD44 were collected using Ni-NTA Agarose (Qiagen) and eluted for analysis by SDS-PAGE and Western blot with merlin antibodies. Of the lysate, 10% was used to determine the total amount of merlin expressed. Quantitation was performing by scanning densitometry as described previously (Gutmann et al, 1999b; Robb et al., 2003) .
In vitro PAK phosphorylation and binding assays GST-merlin-CTD (amino-acid residues 340-595) fusion protein was prepared according to the manufacturer's recommendations (Pharmacia Biotech) and coupled to glutathioneSepharose beads. At 24 h after transfection with 10 mg of Myc-PAK2 cDNA, HEK293 cells were washed once in PBS and lysed in 500 ml lysis buffer A (50 mM Tris, pH 7.4, 40 mM NaCl, 1 mM EDTA, 0.5% Triton X-100, 1.5 mM Na 3 VO 4 , 50 mM NaF, 10 mM sodium pyrophosphate, 10 mM sodium b-glycerophosphate, 1 mM PMSF, 5 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mg/ml pepstatin A), and centrifuged for 10 min at 14 000 g at 41C. A measure of 500 ml of PAK2 or control cell lysate were added to 50 ml GST-merlin-CTD (amino-acid residues 340-595) or GST alone agarose, and incubated with slow rotation at 30 1 C for 30 min, and were washed three times with 500 ml lysis buffer. The agarose then was incubated with HEK293 cell lysate containing HA-merlin (amino-acid residues 1-332) at 41C for 2 h. After three times wash, the beads were resuspended in 30 ml sample buffer separated by SDS-PAGE followed by immunoblotting with anti-HA-HRP antibody at a 1 : 2000 dilution. Equal loading of GST or GST fusion proteins was confirmed with Coomassie blue staining.
Co-immunoprecipitation of C-term/N-term domains of merlin HEK293 cells were cotransfected with 5 mg each of HA-tagged N-merlin (amino-acid residues 1-332), mammalian GSTtagged merlin CTD-I (amino-acid residues 342-595) or merlin CTD-II (amino-acid residues 342-590), and Myc-PAK2 or empty vector. The supernatant was prepared as above. After normalizing the protein concentration, 40 ml 50% slurry glutathione beads were added to the supernatant and incubated with rotation at 41C for 3 h. The pellet was washed three times with 500 ml lysis buffer each time, then resuspended in 30 ml sample buffer and resolved by SDS-PAGE followed by immunoblotting using anti-HA antibody at a 1 : 2000 dilution. The protein expression levels were confirmed by immunoblotting analysis with anti-HA, Myc and GST antibodies.
